Zymergen

With unparalleled scale in laboratory automation and computation, Zymergen builds and optimizes the microbes that serve as cellular factories in the $100B+ industrial biotech sector. Zymergen's products -- optimized cellular factories -- drop directly into our customers' existing bio-manufacturing workflows for immediate impact on their bottom line without additional investments in infrastructure and capital equipment.

Zymergen employs radical empiricism to design, generate, and optimize microbes by rewriting their DNA. Our approach combines biology, robotic automation, and proprietary computational and analytic methods to industrialize what to date has been a slow, risky, essentially artisanal process. As a result, we generate microbes that produce novel chemicals, advanced materials, and pharmaceuticals faster and at lower costs than competing technology.